Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05687344 · ClinicalTrials.gov registry record · Phase 3
Intensive Postpartum Antihypertensive Treatment
A Phase 3 study of Hypertensive Disorder of Pregnancy, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05687344: Active Phase 3 study of Hypertensive Disorder of Pregnancy, sponsored by Medical College of Wisconsin.
NCT05687344 is a Phase 3 study of Hypertensive Disorder of Pregnancy that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 60 participants, below the 2,692-participant average among 8 other Hypertensive Disorder of Pregnancy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05687344, a Phase 3 study of Hypertensive Disorder of Pregnancy, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.
Primary Outcome
Proportion of patients who enroll out of all approached, eligible patients.
Conditions Studied
Interventions
- DRUG Nifedipine ER
Study Locations (1)
Wisconsin
- Froedtert Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2026-03 |
| Phase | Phase 3 |
What the registry record for NCT05687344 still lists
NCT05687344 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,692-participant average among 8 other Hypertensive Disorder of Pregnancy trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Hypertensive Disorder of Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Nifedipine ER is the first listed.
NCT05687344 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05687344 about?
NCT05687344 is a clinical study titled "Intensive Postpartum Antihypertensive Treatment". The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of ...
What is the current status of trial NCT05687344?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2023-09-01. Estimated completion is 2026-03.
What conditions does trial NCT05687344 study?
This clinical trial studies the following conditions: Hypertensive Disorder of Pregnancy.
What interventions are being tested in trial NCT05687344?
The interventions under investigation include: Nifedipine ER (DRUG).
Who is sponsoring clinical trial NCT05687344?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05687344 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertensive Disorder of Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05687344's enrollment target sits among peer trials
60 8th of 8 the lowest of 8 other Hypertensive Disorder of Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertensive Disorder of Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
The Preeclampsia Registry
RECRUITING
-
Platelets in Pregnancy
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI